OxyBand is an FDA cleared, advanced technology that provides transdermal delivery of 100% oxygen to both acute wounds and chronic ulcers directly from the patented reservoir system inside of OxyBand. The device delivers oxygen continuously via sustained release over an extended period of time, up to 5 days as long as OxyBand remains intact and secure around the perimeter. OxyBand has been tested to provide high levels of oxygen to wounds. In a bench test OxyBand was shown to provide 100% oxygen over five days to 65% oxygen (air is 21%). In an in vivo, porcine study OxyBand was shown to increase wound oxygen levels (pO2) at normobaric to, 160-228mmHg and post Hyperbaric, OxyBand was shown to elevate and maintain wound oxygen level (pO2) to 256 mmHg - 260 mmHg (slightly above atmospheric), compared to standard of care that did not increase and maintain a high level of pO2. OxyBand has been shown in 2 randomized controlled and one double blind trial to; significantly accelerate wound healing, significantly reduce pain without infection. Learn more